1 / 67

“Three Cases”

“Three Cases”. Thomas Landgraf, O.D., F.A.A.O. UMSL College of Optometry Fall 2008. Case #1. My Worst? Case Ever Of Herpes Zoster Ophthalmicus S: 36 yo AA male Augmentin, neurontin, “pain med with codeine”, acyclovir

melva
Download Presentation

“Three Cases”

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. “Three Cases” Thomas Landgraf, O.D., F.A.A.O. UMSL College of Optometry Fall 2008

  2. Case #1 • My Worst? Case Ever Of Herpes Zoster Ophthalmicus • S: • 36 yo AA male • Augmentin, neurontin, “pain med with codeine”, acyclovir • Blur, dryness, discharge, redness, grittiness, itching, burning, tearing, light sensitivity, pain, tiredness, fever

  3. Neurontin

  4. Case #1 • My Worst? Case Ever • S: • 2-11-04 • H/O HZO , OD red with “matting” and burning • Right facial skin lesions involving nose • Onset 6 days ago • Began Acyclovir 800 mg 5x/day 1 day ago

  5. Case #1 • My Worst? Case Ever • O: • VA: 20/200 (ph 20/30), 20/20 • SLE: diffuse SPK with pseudodendrites, endothelial KP’s, at least 3+ cells, 3+ conjunctival injection OD • IOP: 15 OU

  6. Case #1 • My Worst? Case Ever • A/P • HZO with severe uveitis and pseudodendrites OD • Prednisolone Acetate 1% q2h OD, Homatropine 5% bid OD, Tobramycin qid OD, Bacitracin ung bid to lesions • CPM per PCP

  7. Case #1 • My Worst? Case Ever • 2-13-04 (2 days later) • Improvement in signs symptoms? • “tested for HIV…no results yet” • VA 20/400 (ph 20/200) • Diffuse SPK with pseudodendrites, ALL 3+ KP’s, corneal edema and striae, conjunctival chemosis and injection, GD 2-3 cells

  8. Case #1 • My Worst? Case Ever • 2-13-04 • Unable to assess retina • IOP: 16 • A/P: HZO with slight improvement in AC reaction, decreased VA secondary to corneal edema, CPM

  9. Case #1 • My Worst? Case Ever • 2/16/04 (3 days later) • “skin lesions better” • “vision not good and eye discomfort” • VA 20/400 (phni) • SLE the same but corneal edema worse and ptosis present

  10. Case #1 • My Worst? Case Ever • 2/16/04 (3 days later) • IOP: 19 • A/P: same assessment except worse overall • change Pred Acetate 1% to QID, Add Viroptic 9x/day x 1 week, otherwise CPM

  11. Dendrites or pseudo dendrites?

  12. Dendrites or Pseudodendrites? • Pseudodendrites stain lightly with NaFl but vividly with RB • No NaFl staining of terminal bulbs • Pseudodendrites are more linear…I.E. not like a “branched-tree root system”

  13. Case #1 • My Worst? Case Ever • 2/16/04 • A/P: HELP…refer to corneal specialist for second opinion • Colleague worried about the patient…

  14. Case #1 • My Worst? Case Ever • 1st visit prior to consult • 3+ eye pain, decreased VA • Bullae and increased IOP (29) • Decreased pseudodendrites • Added Medrol dose pack, NaCl drops, Pred 6x/day, D/C Tobramycin • Lots of patient education

  15. Case #1 • My Worst? Case Ever • 2nd visit prior to consult • Finally, some definite improvement • Decreased eye pain • Pinhole 20/80, no microbullae, IOP normal • CPM

  16. Case #1 • My Worst? Case Ever • Consult • Agreed with management • Gave taper schedule

  17. Case #1 • My Worst? Case Ever • Make a long story short • 4/6/04 • No eye pain, mild photophobia, tearing, mattering in AM • Still on Pred 6x/day • Skin lesions resolved • Ptosis, trace cells, mild SPK and injection, tonometry 19, retina fine • VA 20/25

  18. Case #1 • What did I learn • HZO oral meds may include more than Acyclovir • Prednisone • Narcotic • Neurontin • Analgesic to treat the pain associated with PHN

  19. Case #1 • Keep in Mind with HZO: Zovirax (Acyclovir) • 800 mg 5x/day for 7 days • Within 72 hours • Generic available • Remarkably safe • Alternatives • Valtex (valacyclovir) 1 gram tid x 7d • Famvir (famciclovir) 500 mg tid x 7d

  20. Case #1 • Keep in Mind with HZO: Zovirax (Acyclovir) • For HSK • 400 mg 5x/day for 7d as alternative to topicals • Benefits • concurrent topically treated uveitis • Suppresses recurrence of epithelial and stromal disease (400 mg 5x/day for 12 months) • Thyeson’s SPK?

  21. Case #2: OIS Diagnosis Made Even More Difficult • OIS: Ocular Ischemic Syndrome • History • 79 yo African-American female • Painful and severe vision loss OD • 4 days duration • Pertinent negatives: • Jaw claudication, weight loss, temporal artery associated pain, amaurosis fugax or other TIA

  22. Case #2: OIS DX Even More Difficult • History: • Current medically treated conditions • Hypertension • Congestive heart failure • Possible stroke 3 years prior • POAG, taking Alphagan-P bid OU

  23. Case #2: OIS DX Even More Difficult • Exam • BVA: FC @ 8’ OD, 20/20 OS • Normal CF’s and EOM’s • Pupil OD: 5mm, non-reactive • OS peaked and reactive to light

  24. Case #2: OIS DX Even More Difficult • Exam • SLX: • Iris neovascularization OD • Mild conjunctival hyperemia • PCIOL’s OU • IOP’s: 26 mm Hg OD, 18 OS at 1:25 pm

  25. Case #2: OIS DX Even More Difficult • Exam • DFE • Mild attenuated vessels and macular mottling OU • C/D’s: .7/.6 OD and .5/.5 OS • Normal ONH color and margins OU

  26. Case #2: OIS DX Even More Difficult • Assessment • Acute vison loss OD • Fixed dilated pupil • Increased IOP • Iris neovascularization

  27. Case #2: OIS DX Even More Difficult • Plan: • Referred immediately to ophthalmic co-management center • Second opinion • Continue Alphagan-P

  28. Case #2: OIS DX Even More Difficult • Consultation: • OIS versus retinal occlusive disease • Carotid bruit right side • Referred for carotid ultrasound • Bilateral plaque formation • 60-70% right carotid stenosis • 40-50% left carotid stenosis • Lumen narrowing of right common carotid, normal vertebral blood flow bilaterally

  29. Co-Management

  30. Case #2: OIS DX Even More Difficult • Eventually: • Fluorescein Angiography of the iris and retina • 19 months post-onset: • Shunt disc vessels, retinal capillary non-perfusion, neovascularization • PRA (Pan-Retinal Ablation) performed to prevent pain

  31. Photos Pre-PRA

  32. Photos Post-PRA

  33. Case #2: OIS DX Even More Difficult • Eventually: • Assessments: POAG and Neovascular Glaucoma • Plan: monitor for increased IOP

  34. Case #2: OIS DX Even More Difficult • Most recent optometric follow-up • 29 months post-onset • No eye pain • Travatan qhs and Azopt tid OU • NLP OD, 20/30 OS • Pupillary, iris, posterior pole findings stable OD • IOP’s: 32 OD and 21 OS • Review of recent GDx, OCT, and VF results

  35. Most recent GDx

  36. Most recent OCT RNFL

  37. Most recent VF OS

  38. Case #2: OIS DX Even More Difficult • Most recent optometric follow-up • 29 months post-onset • Additionally Rx Alphagan-P bid OU • Refer to retinal specialist • Additional IOP lowering management regimens OD • She reports follow-up with PCP regarding carotid ultrasound • We have kept the PCP appraised

  39. Case #2: OIS • Background • Rare and blinding condition • Associated with serious systemic morbidity • Unilateral • Average age of onset: 64 years • Associated systemic conditions: HTN, DM, ischemic heart disease, CVA, peripheral vascular disease

  40. CASE #2: OIS • Background • Cause: decreased blood flow to the eye • Results: anterior and posterior segment ischemia • Most patients: severe carotid artery disease

  41. CASE #2: OIS • Symptoms • Decreased vision • Eye pain • Amaurosis fugax

  42. Case #2: OIS • Signs • NVI, NVG, uveitis, cataract, red eye • Pupil rarely involved • Hypoperfusion retinopathy • Narrowed retinal arterioles, hemorrhages, dilated veins, microaneurysms, NVD, NVE, collateral vessels, cherry red spot

  43. Case #2: OIS • Differential Diagnosis • Retinal vascular occlusive disease • Diabetic retinopathy • Hypertensive retinopathy • Ischemic optic neuropathy

  44. Case #2: OIS • Management: difficult and controversial • PRA if retinal ischemia • Carotid endarterectomy? • Reduction of IOP, including cyclocryotherapy

  45. CASE #2: OIS • Bottom Lines for the Primary Care O.D. • Diverse and subtle presentation • Vision and life-threatening • Referral, angiography, carotid artery imaging

  46. CASE #2: OIS • Ocular management: long-term IOP reduction and prevention of eye pain • Systemic management: stresses prevention of ischemic heart disease and stroke

  47. Case #3 • The Post-Op Beyond 90 Days • S: 11/21/02 • 58 yo African-American female • Cataract surgery: • OD on 8/30/02 • OS on 6/21/02

  48. Case #3 • The Post-Op Beyond 90 Days • S: • Significant cardiovascular disease • Type II DM • “eyes feel good” • H/O PRA OU

  49. Case #3 • The Post-Op Beyond 90 Days • O: • BVA 20/30 OD and OS • 2+ AC cells OU • Posterior pole hemes OU • Macula clear OU

  50. Case #3 • The Post-Op Beyond 90 Days • A: • Persistent uveitis after cataract surgery OU • NPDR OU

More Related